The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 640 participants.
Also called NCT03627130
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 640 participants
- Sponsor
- Registry
-
NCT03627130
-
- Other papers using this trial's data
- Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03627130. Randomized; quadruple masking; primary purpose treatment. Start 2018-11-29 (actual); primary completion 2022-05-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
- Acronym
- NITRATE-CIN
- Condition
- Contrast-induced Nephropathy
- Condition
- Acute Kidney Injury
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Potassium Nitrate
- Intervention (Drug)
- Potassium Chloride
- Lead sponsor
- Barts & The London NHS Trust
Record details
- Record id
cardio:ct-nct03627130- Content hash
e9740dd4e178965dbc50ee9064124de01c676f6adae06a7bb104390945ee7632